SettleSignal
Settlements Data breachConsumer refundsPrivacy & biometricsEmployment How we verify Guides Help center For business Log in See what you may be owed →
GreenLight Biosciences Settlement defendant
Evidence-verified Closed Jul 29, 2026 Proof needed

Every dollar amount and date on this page is quoted from the official settlement document.

GreenLight Biosciences Merger $2M Securities Settlement

This settlement is closed. The claim deadline was July 29, 2026. It’s listed here for reference — the claim window has closed. Browse settlements open for claims →

Greenlight Biosciences Holdings, PBC settled a securities lawsuit over the terms of its 2023 merger, in which shareholders' stock was exchanged for $0.30 per share. The company agreed to a $2 million fund for shareholders who held stock during the June 21 to July 20, 2023 tender offer period. The claim filing window closed on July 29, 2026.

Official eligibility wording

All record and beneficial holders of Greenlight Biosciences Holdings, PBC common stock who held during the tender offer period (June 21, 2023 through July 20, 2023) and had shares exchanged for $0.30 per share when the merger closed on July 24, 2023. Checked against the official settlement source by SettleSignal on June 19, 2026.

Key facts

  • Who may qualify Record and beneficial holders of Greenlight Biosciences Holdings, PBC common stock who held shares during the tender offer period (June 21 to July 20, 2023) and had them exchanged for $0.30 per share when the merger closed on July 24, 2023.
  • Estimated payout$2,000,000.00 total fund; approximately $0.04 per share after deductions, distributed pro rata; minimum $10 threshold
  • Claim deadlineJuly 29, 2026 (closed)
  • Objection deadlineJune 15, 2026 (passed)
  • Proof requiredYes
  • What you needThe July 29, 2026 claim deadline has passed; no new claims are being accepted.
  • CourtCourt of Chancery of the State of Delaware

What you'll need to file

From our inspection of the official claim form:

  • Filing method Online or mail-in
  • Notice ID Not needed
  • Documentation Copies of broker confirmations or other documentation (trade confirmations or screenshots) of GreenLight holdings at the Tender Offer expiration (July 20, 2023) are requested if readily available; failure to provide cou…

How hard is this claim to file?

If you held GreenLight Biosciences common stock during the tender offer period and had your shares exchanged when the merger closed, you must submit a claim to receive any payment — no claim means no payout. This claim form asks for 2 fields and 3 documents.

What the form asks

  • — Your personal SSN or, for entities, your federal taxpayer identification number (EIN). (Your tax documents, prior-year tax returns, or IRS correspondence.)
  • — The exact number of shares of GreenLight common stock you held at the expiration of the tender offer on July 20, 2023, that were cashed out when the merger closed. (Your brokerage account statement or trade confirmation from the period around July 20–24, 2023.)

Documents you'll need

Watch out for

  • This is a non-opt-out class — you cannot exclude yourself from the settlement, and you will be bound by its terms whether or not you file.
  • Class members whose calculated payment falls below the minimum threshold will not receive any payout even if their claim is valid.
  • Authorized representatives (executors, trustees, heirs, etc.) must provide proof of their authority to submit on behalf of another person or entity.
  • Payments will only be issued after all claims are processed and the court grants final approval — delays from appeals may push the payout date further out.
  • If total recognized claims exceed the net settlement fund, individual payments will be reduced proportionally.

We prepare — you file on the official site yourself. This is not legal advice and is not an eligibility decision; the administrator and court decide.

Verify it yourself

How we verified this record

How we verify records →

Verification in progress 7 / 8 fields checked against the official settlement website on June 19, 2026
  • Claim deadline
  • Payout details
  • Eligibility
  • Proof requirement
  • Administrator
  • Court case
  • Payment status
  • 1 field queued for re-check

1 official source linked to this record.

Every check below was verified against the official settlement website on June 19, 2026.

  • Claim deadline

    July 29, 2026

  • Proof requirement

    Yes

  • Payment status

    Claim period open

  • Estimated payout

    $2,000,000.00 total fund; approximately $0.04 per share after deductions, distributed pro rata; minimum $10 threshold

  • Administrator

    RG/2 Claims Administration LLC

Show all 6 more verified fields
  • Objection deadline

    June 15, 2026

  • Class period start

    June 21, 2023

  • Class period end

    July 20, 2023

  • Court

    Court of Chancery of the State of Delaware

  • Court case number

    2024-1020-KSJM

  • Case name

    Greenlight Bio Merger Stockholder Litigation

Where to act

Claim window closed

The claim link is hidden because the record is not in an open claim window.

Status history

  1. Claim deadline passed.
  2. Settlement published after verification.
  3. Verified field details updated from an official source.
SettleSignal summary card for GreenLight Biosciences Merger $2M Securities Settlement — $2M fund, claim by July 29, 2026. Accepted official evidence on file.